Effective drug combinations in breast, colon and pancreatic cancer cells.

ABSTRACT: Combinations of anti-cancer drugs can overcome resistance and provide new treatments^1,2. The number of possible drug combinations vastly exceeds what could be tested clinically. Efforts to systematically identify active combinations and the tissues and molecular contexts in which they are most effective could accelerate the development of combination treatments. Here we evaluate the potency and efficacy of 2,025 clinically relevant two-drug combinations, generating a dataset encompassing 125 molecularly characterized breast, colorectal and pancreatic cancer cell lines. We show that synergy between drugs is rare and highly context-dependent, and that combinations of targeted agents are most likely to be synergistic. We incorporate multi-omic molecular features to identify combina

SUBMITTER: Jaaks P 

PROVIDER: S-EPMC8891012 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature